Albertsons is the latest company to settle a series of lawsuits claiming its pharmacies helped fuel the nation’s opioid ...

The supermarket chain spent over $1.8 billion on capital expenditures during fiscal 2025 and expects that figure to be at ...

During the quarter, Albertsons booked a loss of $773.8m, or $599.8m after tax, linked to the opioid settlement framework.

Albertsons Cos. announced a $774 million settlement to resolve all opioid-related claims, making the grocery chain one of the ...

Albertsons plans $2 billion in buybacks over three years, aiming to boost EPS if margins hold steady. See why ACI stock is a ...

Grocery giant reports $480.8M net loss for Q4 due to settlement charges, even as pharmacy sales drove ID sales growth ...

One of the nation’s largest supermarket chains will pay hundreds of millions of dollars to settle claims related to the ...

Attorney General Kwame Raoul announces $773M settlement with Albertsons to address opioid epidemic impact across Illinois and ...

Q4 FY2025 earnings call highlights: comps +0.7%, EBITDA $903M, FY26 EPS/EBITDA outlook, IRA pharmacy headwinds & buybacks—read now.

Albertsons holds same store sales steady as lower-income shoppers pull back by using AI-driven personalization, loyalty and ...

Albertsons’s stock was falling Tuesday after a sales miss and an announcement that the grocery-store chain has reached a $774 ...

A fourth-quarter opioid settlement set back Albertsons. The grocer’s identical sales increased 0.7% year over year, while net ...